Passa al contenuto
Merck

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

SML2591

SCH-39166 hydrobromide

≥98% (HPLC), D1/D5 subtype-selective dopamine receptor antagonist , powder

Sinonimo/i:

(-)-trans-6,7,7a,8,9,13b-Hexahydro-3-chloro-2-hydroxy-N-methyl- 5H-benzo[d]naptho-(2,1-b)azepine hydrobromide, (6aS,13bR)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide, (6aS-trans)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-Benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide, Ecopipam hydrobromide, PSYRX 101 hydrobromide, PSYRX-101 hydrobromide, PSYRX101 hydrobromide, SCH 39166 hydrobromide, SCH39166 hydrobromide

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
5 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 111.00
25 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 448.00
CHF 380.80

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C19H20ClNO·HBr
Numero CAS:
2587360-22-1
Peso molecolare:
394.73
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
MFCD08703109
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated

CHF 111.00

Per conoscere la disponibilità, visualizza il carrello
​
Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

Nome del prodotto

SCH-39166 hydrobromide, ≥98% (HPLC)

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Biochem/physiol Actions

High-affinity D1/D5 subtype-selective dopamine receptor antagonist with in vitro and in vivo efficacy.
SCH-39166 (ecopipam) is a high-affinity D1/D5 subtype-selective dopamine receptor antagonist (Ki = 1.2 nM/D1, 2.0 nM/D5, 980 nM/D2, 5.52 μM/D4, 80 nM/5-HT, 731 nM/α2a). SCH-39166 is widely employed both in cultures and in animal studies in vivo.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
SML2058A5879162957
SCH-39166 hydrobromide ≥98% (HPLC)

Sigma-Aldrich

SML2591

SCH-39166 hydrobromide

5,7-Dihydroxytryptamine hydrobromide ≥94% (HPLC)

Sigma-Aldrich

SML2058

5,7-Dihydroxytryptamine hydrobromide

2-(2-Aminoethyl)isothiourea dihydrobromide

Sigma-Aldrich

A5879

2-(2-Aminoethyl)isothiourea dihydrobromide

6-Hydroxydopamine hydrobromide 95%

Sigma-Aldrich

162957

6-Hydroxydopamine hydrobromide

assay

≥98% (HPLC)

assay

≥94% (HPLC)

assay

≥98% (TLC)

assay

95%

form

powder

form

powder

form

powder

form

powder

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

-

storage temp.

−20°C

storage condition

desiccated

storage condition

desiccated

storage condition

-

storage condition

-

solubility

DMSO: 2 mg/mL, clear

solubility

H2O: 2 mg/mL, clear

solubility

water: 50 mg/mL, clear to very slightly hazy, colorless to yellow

solubility

-

color

white to beige

color

white to dark brown

color

-

color

-

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H302,H315

Hazard Classifications

Acute Tox. 4 Oral - Skin Irrit. 2

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
0000536856
0000536856
0000508872
0000424152
0000424147

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Martin Clark et al.
Frontiers in cellular neuroscience, 12, 260-260 (2018-09-07)
The ventral pallidum (VP) is crucially involved in reward processing. Dopaminergic afferents reach the VP from the ventral tegmental area (VTA). Recent in vivo studies suggest dopamine application increase the firing in the VP. However, little is known about the
Takeshi Enomoto et al.
Behavioral neuroscience, 132(6), 526-535 (2018-10-10)
Effort-based decision-making paradigms have recently been used to measure motivation in healthy subjects and patients with neuropsychiatric disorders. In the present study, we developed a novel effort-discounting paradigm using a touch-panel system in common marmosets. Marmosets were trained to choose
Nao Matsuyama et al.
Respiratory research, 19(1), 53-53 (2018-04-03)
Dopamine receptors comprise two subgroups, Gs protein-coupled “D1-like” receptors (D1, D5) and Gicoupled “D2-like” receptors (D2, D3, D4). In airways, both dopamine D1 and D2 receptors are expressed on airway smooth muscle and regulate airway smooth muscle force. However, functional
Visualizza tutti i documenti correlati

Questions

Reviews

No rating value

Active Filters